Therapeutic options in the management of acromegaly: focus on lanreotide Autogel®

por Ferdin, Roelfsema, Nienke R Biermasz, Alberto M Pereira, Johannes A Romijn
Publicado 2008

Acute central neuropeptide Y administration increases food intake but does not affect hepatic very low-density lipoprotein (VLDL) production in mice.

por Janine J Geerling, Yanan Wang, Louis M Havekes, Johannes A Romijn, Patrick C N Rensen
Publicado 2013

Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP mice.

por Hanna E Auvinen, Yanan Wang, Hans Princen, Johannes A Romijn, Louis M Havekes, Johannes W A Smit, Onno C Meijer, Nienke R Biermasz, Patrick C N Rensen, Alberto M Pereira
Publicado 2013

GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice.

por Edwin T Parlevliet, Yanan Wang, Janine J Geerling, Janny P Schröder-Van der Elst, Kristen Picha, Karyn O'Neil, Vedrana Stojanovic-Susulic, Tatiana Ort, Louis M Havekes, Johannes A Romijn, Hanno Pijl, Patrick C N Rensen
Publicado 2012